DYNAVAX TECHNOLOGIES

DVAX
Delayed Quote. Delayed  - 01/27 04:00:00 pm
6.14USD -0.49%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 35,240,1
EBITDA --
Operating profit (EBIT)1 -135-77,8
Operating Margin -383%-194%
Pre-Tax Profit (EBT)1 -153-87,2
Net income1 -156-87,3
Net margin -443%-218%
EPS2 -2,16-0,86
Dividend per Share --
Last update 03/11/2020-
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt --
Net Cash position --
Leverage (Debt / EBITDA) --
Free Cash Flow1 -145-87,0
ROE (Net Profit / Equities) --
Shareholders' equity1 --
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share --
Cash Flow per Share --
Capex1 22,44,30
Capex / Sales 63,6%10,7%
Last update 03/11/202001/07/2021
1 USD in Million
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 676 M $ -
Valuation 2020e 2021e
P/E ratio (Price / EPS) -7,14x -13,5x
Capitalization / Revenue 16,9x 5,43x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) -194% -38,2%
Operating Leverage (Delta EBIT / Delta Sales) 3,08x 0,18x
Net Margin (Net Profit / Revenue) -218% -40,9%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   10,7% 3,21%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend